Israel vs Republic of Korea: Patent applications to the EPO by priority year by NACE Rev. 2
Israel
5.47 Number
in 2013
Republic of Korea
5.21 Number
in 2013
Israel rank
19th
Republic of Korea rank
20th
Patent applications to the EPO by priority year by NACE Rev. 2 over time
- Israel
- Republic of Korea
How they compare
Israel currently reports 5.47 Number against 5.21 Number in Republic of Korea, a difference of 0.26 Number.
The two have swapped places 8 times across 25 shared years of data; in 1986 it was Israel ahead.
Israel ranks 19th and Republic of Korea ranks 20th of 56 countries.
Across the 4 decades both report, Israel averaged higher in 3 and Republic of Korea in 1.
Head to head by decade
| Decade | Israel | Republic of Korea | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.23 Number | 0.256 Number | 1.98 Number | Israel |
| 1990s | 3.95 Number | 1.83 Number | 2.13 Number | Israel |
| 2000s | 9.19 Number | 10.62 Number | 1.42 Number | Republic of Korea |
| 2010s | 10.45 Number | 8.22 Number | 2.23 Number | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher patent applications to the epo by priority year by nace rev. 2, Israel or Republic of Korea?
- Israel, at 5.47 Number against 5.21 Number in Republic of Korea as of 2013.
- What is the difference in patent applications to the epo by priority year by nace rev. 2 between Israel and Republic of Korea?
- 0.26 Number, with Israel ahead.
- How many years of comparable data are there for Israel and Republic of Korea?
- 25 years are reported by both, from 1986 to 2013.
- How do Israel and Republic of Korea rank globally for patent applications to the epo by priority year by nace rev. 2?
- Israel ranks 19th and Republic of Korea ranks 20th of 56 countries.
- Where does this data come from?
- Eurostat, published as Patent applications to the EPO by priority year by NACE Rev. 2 activity (1977-2012). Statizoid refreshes it automatically from the source and publishes the full history for both places.